Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
60
REGN Quote, Financials, Valuation and Earnings
Last price:
$784.09
Seasonality move
:
12.13%
Day range:
$777.00 - $792.75
52-week range:
$476.49 - $792.75
Dividend yield:
0.45%
P/E ratio:
18.80x
P/S ratio:
6.07x
P/B ratio:
2.67x
Volume:
832K
Avg. volume:
1.1M
1-year change:
9.79%
Market cap:
$82.5B
Revenue:
$14.2B
EPS (TTM):
$41.77
Earnings Data
Next earnings date for REGN
Feb 03
2026
Most recent earnings per share
$13.62
Beat by $3.97
(Oct 28/2025)
Consensus Estimate
$9.64
(Oct 28/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
REGN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/03/2026 | Q4 | $3.8B | -- | -- | $10.71 | -- |
| 10/28/2025 | Q3 | $3.6B | $3.8B | $13.62 | $9.64 | $3.97 |
| 08/01/2025 | Q2 | $3.3B | $3.7B | $12.81 | $8.44 | $4.37 |
| 04/29/2025 | Q1 | $3.2B | $3B | $7.27 | $8.48 | -$1.20 |
| 02/04/2025 | Q4 | $3.7B | $3.8B | $8.06 | $11.19 | -$3.13 |
| 10/31/2024 | Q3 | $3.7B | $3.7B | $11.54 | $11.70 | -$0.16 |
| 08/01/2024 | Q2 | $3.4B | $3.5B | $12.41 | $10.62 | $1.79 |
| 05/02/2024 | Q1 | $3.2B | $3.1B | $6.27 | $10.10 | -$3.82 |
| 02/02/2024 | Q4 | $3.3B | $3.4B | $10.19 | $10.75 | -$0.56 |
| 11/02/2023 | Q3 | -- | $3.4B | $8.89 | -- | -- |
| 08/03/2023 | Q2 | -- | $3.2B | $8.50 | -- | -- |
| 05/04/2023 | Q1 | -- | $3.2B | $7.17 | -- | -- |
| 02/03/2023 | Q4 | -- | $3.4B | $10.50 | -- | -- |
| 11/03/2022 | Q3 | -- | $2.9B | $11.66 | -- | -- |
| 08/03/2022 | Q2 | -- | $2.9B | $7.47 | -- | -- |
| 05/04/2022 | Q1 | -- | $3B | $8.61 | -- | -- |
| 02/04/2022 | Q4 | -- | $5B | $19.69 | -- | -- |
| 11/04/2021 | Q3 | -- | $3.5B | $14.33 | -- | -- |
| 08/05/2021 | Q2 | -- | $5.1B | $27.97 | -- | -- |
| 05/06/2021 | Q1 | -- | $2.5B | $10.09 | -- | -- |
| 02/05/2021 | Q4 | -- | $2.4B | $10.24 | -- | -- |
| 11/05/2020 | Q3 | -- | $2.3B | $7.39 | -- | -- |
| 08/05/2020 | Q2 | -- | $2B | $7.61 | -- | -- |
| 05/05/2020 | Q1 | -- | $1.8B | $5.43 | -- | -- |
| 02/06/2020 | Q4 | -- | $1.9B | $6.93 | -- | -- |
| 11/05/2019 | Q3 | -- | $1.7B | $5.86 | -- | -- |
| 08/06/2019 | Q2 | -- | $1.6B | $1.69 | -- | -- |
| 05/07/2019 | Q1 | -- | $1.4B | $3.99 | -- | -- |
| 02/06/2019 | Q4 | -- | $1.9B | $7.15 | -- | -- |
| 11/06/2018 | Q3 | -- | $1.7B | $5.17 | -- | -- |
| 08/02/2018 | Q2 | -- | $1.6B | $4.82 | -- | -- |
| 05/03/2018 | Q1 | -- | $1.5B | $4.16 | -- | -- |
| 02/08/2018 | Q4 | -- | $1.6B | $1.50 | -- | -- |
| 11/08/2017 | Q3 | -- | $1.5B | $3.32 | -- | -- |
| 08/03/2017 | Q2 | -- | $1.5B | $3.34 | -- | -- |
| 05/04/2017 | Q1 | -- | $1.3B | $2.16 | -- | -- |
| 02/09/2017 | Q4 | -- | $1.2B | $2.19 | -- | -- |
| 11/04/2016 | Q3 | -- | $1.2B | $2.27 | -- | -- |
| 08/04/2016 | Q2 | -- | $1.2B | $1.69 | -- | -- |
| 05/05/2016 | Q1 | -- | $1.2B | $1.59 | -- | -- |
| 02/09/2016 | Q4 | -- | $1.1B | $1.34 | -- | -- |
Regeneron Pharmaceuticals, Inc. Earnings Questions
-
How Much did Regeneron Pharmaceuticals, Inc. Generate in Revenue Last Quarter?
Regeneron Pharmaceuticals, Inc. reported $3.8B worth of top line sales in its most recent quarter.
-
Did Regeneron Pharmaceuticals, Inc. Beat Earnings Last Quarter?
Regeneron Pharmaceuticals, Inc. announced earnings per share of $13.62 which represents a beat of analyst forecast a $9.64 per share.
-
Is Regeneron Pharmaceuticals, Inc. Profitable?
Regeneron Pharmaceuticals, Inc. reported $3.1B that represents $28.88 per share over the last quarter.
-
What is the Analyst Consensus for Regeneron Pharmaceuticals, Inc. EPS Next Year?
Regeneron Pharmaceuticals, Inc.'s earnings are forecast to grow from $38.34 per share to $44.92 per share next year representing an increase of 12.63%.
-
When is Regeneron Pharmaceuticals, Inc.'s Earnings Date?
Regeneron Pharmaceuticals, Inc.'s next earnings date is February 3, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
